News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clinical Study Demonstrates That Cardiola's M.Pulse(R) System "Immediately Improves Cardiac Output Under Acute Non-Invasive Muscular Counterpulsation (MCP) Treatment In Patients With Patients With Stable CHF" (Chronic Heart Failure)


4/23/2010 9:59:15 AM

WINTERTHUR, Switzerland--(BUSINESS WIRE)--Cardiola AG announced today that the Company’s CE-Marked m.pulse® Muscular CounterPulsation (“MCP”)-based system demonstrated “an immediate improvement of cardiac output with non-invasive means” in a patient population of advanced yet stable chronic heart failure. The effects could be shown in 22 patients over three consecutive days.

Read at BioSpace.com


comments powered by Disqus
Cardiola
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES